Lv4
622 积分 2023-11-15 加入
M2ASeg: Synergistic active-semi supervision with multi-model expertise for medical image segmentation
10天前
已关闭
Multimodal biomedical AI
16天前
已完结
Association of Immune Checkpoint Inhibitor Therapy With Survival in Patients With Cancers With MUC16 Variants
17天前
已完结
Self-improving generative foundation model for synthetic medical image generation and clinical applications
18天前
已完结
PediatricsGPT: Large Language Models as Chinese Medical Assistants for Pediatric Applications
20天前
已完结
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
24天前
已完结
Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study
24天前
已完结
Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study
24天前
已完结
Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial
24天前
已完结
Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial
24天前
已完结
皖公网安备34019202002308
